Verdence Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.05M Buy
13,833
+1,952
+16% +$642K 0.24% 100
2025
Q4
$4.16M Sell
11,881
-8,868
-43% -$3M 0.25% 97
2025
Q3
$7.11M Sell
20,749
-464
-2% -$144K 0.41% 53
2025
Q2
$8.25M Buy
21,213
+790
+4% +$318K 0.56% 36
2025
Q1
$8.88M Buy
20,423
+9,886
+94% +$3.97M 0.68% 29
2024
Q4
$3.89M Sell
10,537
-8,124
-44% -$3.4M 0.31% 77
2024
Q3
$9.7M Buy
18,661
+2,039
+12% +$1.09M 0.77% 23
2024
Q2
$9.01M Buy
16,622
+784
+5% +$414K 0.8% 21
2024
Q1
$8.21M Buy
15,838
+47
+0.3% +$23.4K 0.75% 25
2023
Q4
$7.45M Buy
15,791
+346
+2% +$160K 0.72% 29
2023
Q3
$6.73M Buy
15,445
+1,132
+8% +$513K 0.73% 28
2023
Q2
$6.36M Buy
14,313
+2,250
+19% +$1.04M 0.74% 30
2023
Q1
$5.55M Buy
12,063
+1,801
+18% +$857K 0.67% 32
2022
Q4
$5.26M Sell
10,262
-403
-4% -$205K 0.65% 29
2022
Q3
$4.84M Buy
10,665
+4,043
+61% +$1.93M 0.67% 31
2022
Q2
$3.19M Sell
6,622
-349
-5% -$173K 0.41% 62
2022
Q1
$3.42M Buy
+6,971
New +$3.19M 0.39% 67

Other funds holding ELV

Verdence Capital Advisors's ELV Position: Q1 2026 in Review

Verdence Capital Advisors increased its Elevance Health (ELV) stake by 16% in Q1 2026, buying an estimated $642K and bringing the position to 13,833 shares worth $4.05M. The position accounts for 0.24% of the portfolio, ranked #100.

Verdence Capital Advisors first reported a position in ELV in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.7M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Verdence Capital Advisors held 13,833 shares of Elevance Health worth $4.05M as of Q1 2026.
  • Verdence Capital Advisors bought 1,952 Elevance Health shares in Q1 2026, an estimated $642K.
  • Elevance Health made up 0.24% of Verdence Capital Advisors's portfolio in Q1 2026, its #100 holding.
  • Verdence Capital Advisors first reported a position in Elevance Health in Q1 2022 and has held it in 17 quarters since.
  • Verdence Capital Advisors's Elevance Health position peaked at $9.7M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.